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  Osteonecrosis of the femoral head is a poorly understood 
condition that may lead to progressive destruction of the 
hip joint. Its incidence is common between the third and 
fifth decades of life and it is the diagnosis behind 5–18% 
of annually performed total hip arthroplasties (THAs) in 
the USA.
  Regarding the high rate of complications of THA in that 
age group, authors have agreed on the importance of 
joint-preservation techniques for this disease but tech-
niques vary to establish a generally accepted algorithmic 
approach.
  Surgical head-preserving procedures, core decompression 
with or without graft, stem cell augmentation, or biologic 
adjuncts, vascularized bone grafting, and proximal femo-
ral osteotomies have all been published on with heteroge-
neous results and with limited evidence to date.
  Consensus states that the prognosis of patients with osteo-
necrosis of the femoral head can be significantly improved 
with early diagnosis and timely intervention.
Keywords: avascular necrosis; core decompression; femoral 
head; hip; osteonecrosis; total hip arthroplasty
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Introduction
Osteonecrosis of the femoral head (ONFH) is a multifacto-
rial and poorly understood disease predominantly encoun-
tered in patients in their third to fifth decade of life.1 This 
pathology results from disruption of the subchondral 
blood supply to the femoral head and constitutes a reason 
for total hip arthroplasty (THA) in young patients.1,2 If left 
undiagnosed and untreated, this disease will progress to 
the eventual collapse of the femoral head.1-3 Males are 
three times more affected than females, and bilateral 
ONFH is found in up to 75% of cases.4,5 In general, oste-
onecrosis is responsible for approximately 5–18% of all 
THA cases.6-8 In most countries, the incidence and preva-
lence of avascular necrosis (AVN) are reported based on 
unreliable data consisting of rough estimates on the rate 
of osteonecrosis. Chronic alcohol consumption and ster-
oid administration are the most common aetiologies. 
Asian populations are considered to be more prone to 
developing AVN; in China, the number of new appear-
ances is about 75,000−150,000 per year. Nationwide sur-
veys from Japan and Korea reported the annual prevalence 
at more than 10,000 cases. In Taiwan, about half of the 
total number of hip arthroplasties were carried out due to 
femoral head osteonecrosis.9
Patients with ONFH are typically younger and may not 
have as durable an outcome with standard THA.1 There-
fore, joint-preserving procedures are thought to play an 
important role in the management of these patients.1,3 
Diagnosis of ONFH can also be challenging. Although the 
disease often presents insidiously with gradual onset of 
hip and groin pain, it can frequently be asymptomatic, 
therefore suspicion is judicious for early diagnosis.3,10 Min 
et al reported the natural history of ONFH in 81 asympto-
matic hips with a mean follow-up of 8.3 years.11 Eventu-
ally, 32% of the cases progressed to collapse, underlining 
the benefits of early diagnosis for appropriate care and 
treatment.11
Magnetic resonance imaging (MRI) is an indispensable 
tool for detection of the initial lesion of ONFH with 90–
100% sensitivity.12,13 Despite the lack of concrete data 
regarding the most optimal joint-preservation procedure, 
the prognosis for patients with ONFH can be significantly 
improved with early diagnosis and intervention.3,14
Many variables, such as stage of the disease, patient 
age, lesion size, and lesion location, play an important role 
in selection of the treatment choice.2,3,7,15 While joint- 
preserving techniques have shown significantly improved 
outcomes if used in early, pre-collapsed patients,4,15,16 THA 
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remains the most common technique after collapse of the 
femoral head.16
Johnson et al reported a study utilizing The Nationwide 
Inpatient Sample database in order to determine trends in 
the types and numbers of procedures performed for the 
treatment of osteonecrosis from 1992 to 2008 in the 
United States.16 They found the most frequently reported 
pre-collapse procedure was core decompression whereas 
the most frequently reported post-collapse procedure 
was THA. During the time period evaluated in their sur-
vey, the total number of procedures performed increased 
from 3,570 to 6,400 procedures per year.16 While joint-
preserving procedures declined from 25% to 12%, joint 
replacement increased from 75% of procedures per-
formed to 88%.16 They concluded that the total increase 
of procedures may reflect an improved awareness regard-
ing this disease and more aggressive approaches to diag-
nosis and treatment.
Recent modifications of classic techniques, as well as 
emerging cell engineering technologies, have led to the 
development of alternative strategies that may be able 
to improve the course of ONFH. The aim of this review 
is to describe the efficacy of current joint-preserving 
techniques and their association with different clinical 
presentations.
Management and treatment 
recommendations
In most cases of ONFH, various risk factors have synergis-
tic action in the development of pathogenesis and they 
play a collaborative role in the development of eventual 
collapse. Among these risk factors, aetiology has a major 
role where corticosteroids, immunosuppressive treat-
ment, and sickle cell disease are all associated with less 
favourable outcomes. The difficulty of choosing appro-
priate treatment in patients with these aetiologies and 
absence of consensus requires a comprehensive review.17
Joint-preserving procedures
Core decompression
Core decompression is the most widely cited and most 
controversial technique to reduce pain and to prevent fur-
ther joint deterioration. This technique was first described 
by Ficat and Arlet during their attempt to obtain biopsy 
specimens for confirmation of the diagnosis in the pre-MRI 
era.18 The original core decompression was performed by 
tunnelling of an 8–10 mm trephine into the necrotic lesion. 
The theoretical advantage of core decompression is to pro-
vide pain relief through reducing venous congestion and 
bone-marrow pressure.15,19 With the decrease in intraosse-
ous pressure, blood flow is increased to the necrotic area 
of bone, thus alleviating the pathologic process and pro-
moting neovascularization (see Fig. 1).8,13,19
Today, clinical techniques vary widely. The overall suc-
cess rate as defined by the need for further surgery has 
varied between 40% and 80% across multiple studies at 
two to seven year follow-up.13 The best outcomes have 
been seen in pre-collapsed stages of the disease with small 
(defined as less than 15% of the femoral head or Kerboul 
angle < 200°), medially located lesions.4,13,19-21
Kim et al developed the multiple small-diameter core 
decompression technique with a 3.2 mm drill bit involv-
ing at least three perforations of the necrotic border.20,22 
This procedure is carried out under fluoroscopic guidance 
through the trochanteric ridge.20,22 Later, Mont et  al 
reported in 2004 that both classic large technique and 
the multiple-drilling technique share similar outcomes 
amongst other variables.20 The multiple drilling technique 
is advantageous in that it lessens the complications of 
femoral head penetration and sub-trochanteric fractures 
seen in classic techniques employing larger tunnel decom-
pression.20,23 This multiple drilling approach also more 
easily targets the lesion.23
Reported outcomes of core decompression within the 
literature are controversial in many ways (see Table 1). 
The age of the host, the size and location of the lesion, 
stage of the disease, aetiology and the core decompres-
sion technique used are among the numerous variables 
that have yet to be fully standardized.19,20,22,23 However, 
unequal follow-ups reported in the literature ranging 
from two to five years make it impossible to determine the 
validity of this technique for joint preservation. It has been 
shown that when applied in younger patients, on smaller 
size (lesions < 15% femoral head) and medially located 
lesions it results in better outcomes.15,24-26
Mesenchymal stem cells, bone-marrow implantation or 
growth-factor-based treatment
Osteonecrosis of the femoral head is thought to be charac-
terized by compromised vascular supply, necrosis, and 
subsequent microfracturing without adequate bone 
remodelling and healing.1 It has also been shown that the 
levels of osteoprogenitor cells in the haematopoietic and 
stromal marrow compartments are decreased in this dis-
ease.27,28 The lack of sufficient osteoprogenitor cells com-
promises the ability of the bone to heal and remodel.1,27-30 
In order to promote improved bone healing and revascu-
larization, new cellular-based therapies are being aimed at 
reversing the physiologic damage done to the bone mar-
row and the mesenchymal bone marrow stem cells 
(BMSCs).1,4,5 Augmenting techniques such as core decom-
pression with the addition of these cell-based therapies 
show promise in improving patient outcomes and slow-
ing disease advancement.1,19
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A prospective evaluation of 189 patients with Stage I 
and II hips treated with core decompression and bone-
marrow transplantation, revealed that only 9 of 145 
(6.2%) hips progressed to THA in seven years.29 However, 
the outcome was less successful in patients presenting 
after collapse, with 25 of 45 (55.6%) hips requiring THA.29
A prospective, randomized controlled study by 
Gangji et al demonstrated a significantly improved time 
to collapse, progression of disease, and decreased hip 
pain and joint symptoms when comparing core decom-
pression with autologous BMSCs versus core decom-
pression alone.27 Survival was defined as presence of 
subchondral fracture. Their analysis showed a mean sur-
vival time of 52.2 months (95% CI 43.35–60.96) in the 
BMSC group compared to 26.5 months (95% CI 13.20–
39.75) in the core decompression group (p = 0.008).27 
However, they did not find a significant difference in 
time to arthroplasty between the two groups. A similar 
study by Tabatabaee et al randomized 28 patients into 
core decompression plus BMSC grafting and core 
decompression cohorts. The results of their study were 
similar to Gangji et al, and they found reduced pain and 
joint symptoms and delayed progression of disease with 
the addition of BMSCs.5
Several systematic reviews and meta-analyses have 
been performed in order to further examine the available 
data regarding cell-based therapies. Papakostidis et  al 
performed a systematic review and meta-analysis of 
seven studies examining the efficacy of BMSC in addition 
to core decompression in osteonecrosis of the femoral 
head. Their meta-analysis found that core decompres-
sion with autologous BMSCs was superior to core 
decompression alone in regard to structural failure of the 
femoral head (OR = 0.2, 95% CI 0.08–0.60, p = 0.02).31 
Yuan et  al additionally performed a meta-analysis of 
seven trials to evaluate the clinical outcomes of BMSC 
implantation in cases of osteo necrosis of the femoral 
head. They found delayed progression of osteonecrosis in 
the BMSC group (OR = 0.17, 95% CI 0.09–0.32, p < 
0.001) and a lower incidence of total hip arthroplasty in 
the BMSC group compared to controls (OR = 0.30, 95% 
CI 0.12–0.72, p < 0.01).32 They also found no significant 
heterogeneity amongst their included studies and further 
sensitivity analysis did not reveal any statistical difference 
  
 
Fig. 1 (a & b) Preoperative X-ray and MRI presentation of Ficat-Arlet Stage II osteonecrosis on both hips of a 21-year-old man. (c & 
d) He was treated with classic core decompression, curettage and allograft + DBM augmentation. (e) X-ray demonstrates survival of 
both hips at 11 years follow-up with a remarkable functional outcome.
Notes. MRI, magnetic resonance imaging; DBM, demineralized bone matrix.
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when different studies were excluded.32 A larger more 
recent systematic review by Piuzzi et al, found significant 
heterogeneity amongst the literature despite similarly 
promising results.1 While the results are encouraging, 
there are some inconsistencies in the literature due to 
heterogeneity of the presented cases in terms of the aeti-
ology, lesion size, and disease stage (see Table 2). Fur-
ther studies utilizing large patient groups are necessary 
in order to elucidate not only the true effect of BMSC 
implantation but also the optimal source of mesenchy-
mal stem cells. Although evidence has emerged in favour 
of this therapy, more evidence is needed to produce a 
standardized technique and recommendation.1
Other cellular-based techniques have been described 
and studied in addition to BMSC application. Specifi-
cally, bone morphogenetic protein (BMP) has been used 
as an addition to core decompression due to the biologi-
cal molecule’s ability to promote osteogenesis.33 Lieber-
man et al reported on 15 patients (17 hips) treated with 
core decompression, fibular allograft, and 50 mg of 
human BMP for osteonecrosis of the femoral head.33 All 
17 hips in this retrospective study were in the early pre-
collapsed stage and after follow-up only 3/17 hips 
showed disease progression with subsequent conver-
sion to THA.33 Sun et al, reported on clinical outcomes 
after patients were treated with impacted bone graft 
versus impacted bone graft with recombinant BMP 
(BMP-2).34 Their findings, however, showed no statisti-
cal difference between the study arms.34 Of a more con-
cerning note for this technique, there has been an 
association between BMP and increased cancer risk, 
making this a less ideal method of hip preservation than 
other methods.4
Proximal femoral osteotomies
The goal of proximal femoral osteotomy in osteonecrosis 
is to take the necrotic lesion away from the weight- 
bearing area of the joint and redirect the forces to the 
healthy portion of the head in order to promote healing 
and prevent collapse.13,23 Rotating the femoral head has a 
double effect of reducing the intraosseous venous pres-
sure and promoting neovascularization with the returned 
blood flow.13
A variety of osteotomies are described in the literature 
including rotational transtrochanteric osteotomy (anterior 
and posterior) and angular intertrochanteric osteotomy 
(flexion, extension, varus or valgus and combined using 
various combinations). The success rates of rotational 
transtrochanteric osteotomies have been reported at 70–
93% in Asian countries, with much less success being 
Table 1. Outcomes of core decompression (CD) before/after 1992 (multiple vs. classic CD)
Author Study year N (hips) Stage Technique Mean follow-up Outcome/Survival
Ficat RP18 1985 133 Stage I
Stage II
Classic CD 10 yr 86.6%
66.7%




Classic CD 2.3 yr 70.0%
71.0%
73.0%
Aaron RK55 1989 50 Stage I
Stage II
(Ficat)
Classic CD 3 yr 62.0%
25.0%













Classic CD 11 yr 88.0%
72.0%
26.0%
Bozic KJ58 1999 54 Stage I-II-III
(Ficat&Arlet)
Multiple Drilling 10 yr 48.0%
Mont MA20 2004 45 Stage I
Stage II
(Ficat&Arlet)
Multiple Drilling 2 yr 80.0%
57.0%
Marker BS59 2008 79 Stage I
Stage II
(Ficat)
Multiple Drilling 5.5 yr 79.0%
48.0%




Multiple Drilling 7.25 yr 79.0%
77.0%
35.0%
Kim S22 2004 35 N/A (all pre-collapsed) Multiple drilling 5yr 85.7%
Scully SP61 1998 98 Stage II
Stage III
(Ficat)
Multiple drilling 50 months 65.0%
21.0%
Notes. N/A, not available; CD, core decompression.
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reported in European nations.13,23 However, angular inter-
trochanteric techniques have reported success rates of 
72–98% in the US and Europe after follow-up of 4–12 
years. 23,35
Critics of proximal femoral osteotomy have argued 
that higher complication rates are a result of the more 
technically demanding surgical procedure.8,13,35 Compli-
cations such as fixation failure, delayed or non-unions, 
and difficulty obtaining an ideal position intraoperatively 
have been reported, and likely contribute to the lower 
utilization of this technique.19 In addition, conversion to a 
THA is more difficult if a femoral osteotomy was previ-
ously performed due to the distortion of the proximal 
femur.13,19,36
Zhao et al, after a mean follow-up of 12.4 years (range, 
5–31 years), reported that 91.8% of the hips remained intact 
and did not need conversion to a THA. Results are more 
encouraging in the presence of more than one-third of nor-
mal superolateral bone but varus osteotomy produces 2 cm 
of shortening on the affected limb.35-38 Newer techniques of 
rotational femoral osteotomy were defined to avoid short-
ening of the limb, to unload the necrotic bone and to create 
an environment in which the weight could be dispersed and 
stabilized on healthy cartilage. Ishikwa et  al in their 2015 
article underlined the difficulty of repair in cases presenting 
with advance collapse and extensive necrotic lesions, and 
suggested high-degree posterior rotational osteotomy 
(HDPRO) as an alternative method.39 In their series of 60 
hips, all had extensive collapsed lesions, antero-inferior via-
ble cartilage was transferred to weight-bearing position by 
a mean posterior rotation of 118.5°. Evaluation of the pre-
senting necrotic lesion size with sequential MRI revealed 
19.4–59.5% decrease in one year. The authors concluded 
that extensive necrotic lesions decreased in size rapidly after 
HDPRO in young patients. However, it is technically 
demanding, and this has been a significant drawback to its 
more general acceptance.39
Intertrochanteric techniques have also been reported 
in several case series. Maistrelli et  al found promising 
results at two years follow-up, with 71% of treated hips 
having satisfactory clinical outcomes as measured by Har-
ris Hip Scores.40 Their final follow-up at a mean of 8.2 
years demonstrated a satisfactory survival rate of 58%.40 
Two similar case series by Gallinaro and Massè, and 
Jacobs et al reported similar rates of success with intertro-
chanteric techniques. Jacobs et  al demonstrated a 73% 
success rate at 5.3 years average follow-up, while Gallin-
aro and Massè reported 62.5% success at 10.2 years 
follow-up.41,42
Despite these reported success rates, high levels of evi-
dence are not available for this technique. The majority of 
published literature consists of single-surgeon series, and 
randomized controlled trials have not been performed. A 
review by Chughtai et al identified only a single Level II 
study amongst the literature reporting on ONFH.19 While 
strict selection criteria are required for osteotomies they 
are most successful in patients not being treated with 
long-term corticosteroids, age < 40 years, with a body 
mass index (BMI) less than 25 kg/m2, minimal osteoar-
thritic changes, a postoperative intact ratio of at least 33%, 
Table 2. Outcomes of core decompression augmented with a biologic regenerative agent
Author Study year N (hips) Stage Technique Mean follow-up Outcome/Survival
Lieberman JR33 2004 17 Stage IIa-IIb-III
(Ficat)
CD+BMP 4.5 yr 82.4%
Mont MA62 2007 21 N/A CD+BMP 2 yr 86.0%
Papanagiotou M63 2014 7 Stage II-III
(Steinberg)
CD+BMP-7 4 yr 83.0%
Gangji V64 2005 18 Stage I-II
(ARCO)
CD+ABMMCs 2 yr 90.0%




















Liu Y66 2013 55 Stage II
(ARCO)
CD+ABMMCs 2 yr 78.6%
Zhao D67 2012 104 Stage I-II
(ARCO)
CD+ABMMCs 5 yr 96.2%




CD+ABMMCs 5 yr 64.3%
56.7%
42.9%
Notes. N/A, not available; CD, core decompression; BMP, bone morphogenic protein; ABMMC, autologous bone marrow mononuclear cells.
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and necrotic lesions with a Kerboul’s angle less than 200° 
(see Table 3).13,19,35,36,43
Non-vascularized bone grafting
Non-vascularized bone grafting has typically been 
applied in patients classified with pre- and early collapse 
osteonecrosis of the femoral head.19,44 The principle 
underlying this technique is to remove the necrotic bone 
and replace it with cancellous and cortical autografts in 
order to provide improved structural support for the 
femoral head.44 It is also thought that the grafted bone 
provides inherent osteoinductive and osteoconductive 
properties, allowing it to aid in the healing of the dam-
aged femoral head.19,36 While early studies found favora-
ble results, more recent studies have reported less 
success.44 Non-vascularized bone graft is placed into the 
femoral head using one of three described techniques: 
(1) the Phemister technique, (2) articular cartilage win-
dow or trapdoor technique, and (3) a cortical window 
or ‘lightbulb’ grafting technique.15,19,44
The Phemister technique makes use of a core decom-
pression tract in order to place the grafted bone in the 
affected region.44,45 Despite early reports showing clinical 
success, such as the study by Buckley et al observing 90% 
successful outcomes, later studies found poor long term 
results.46 Smith et al noted that after an average follow-up 
of 14 years, only 29% (16/56) of hips treated with the 
Phemister technique had a satisfactory clinical outcome.47 
Another case series reported by Nelson and Clark sup-
ported these poor clinical outcomes with the Phemister 
technique and also found disease progression even in 
Ficat Stage II hips treated with this technique.48
A trapdoor technique implementing a window in the 
articular cartilage has also been described and utilized in 
the literature. Trapdoor grafting, introduced in 1965, is 
executed from either an anterior or posterolateral 
approach with an open arthrotomy and safe dislocation 
of the femoral head.15 Under direct visualization, a carti-
lage window in the femoral head over the necrotic area 
is created for a debridement of the osteonecrotic lesion 
and impaction of a bone graft (see Fig. 2).15,45 Trapdoor 
grafting has shown favourable results in managing 
advanced femoral head osteonecrosis. Mont et  al 
reported promising results in their case series of Ficat 
Stage III and IV hips, with good or excellent outcomes in 
83% of their patients after an average follow-up of 56 
months.15
Rosenwasser et  al originally described the lightbulb 
technique as the concept of debridement of the necrotic 
area and bone grafting through a cortical window at the 
femoral head–neck junction (see Fig. 3).44,49 This tech-
nique is similar to the trapdoor technique except that it 
spares the articular cartilage. Seyler et al reported a study 
of 39 hips treated with a lightbulb technique. They 
Table 3. Outcomes of osteotomies (transtrochanteric, intertrochanteric, rotational)
Author Study year N (hips) Stage Technique Mean follow-up Outcome/Survival
Jacobs MA42 1989 24 Stage II
Stage III
Intertrochanteric
(varus, valgus, flexion, extension)
5.3 yr 72.7%
Stöve J69 2001 83 Stage I,II,III,IV,V
(Ficat&ARCO)
Intertrochanteric 7 yr 69.2%
Sakano S70 2004 20 Stage II-III-IV
(Ficat)
Intertrochanteric ostetomies (varus) 4 yr 90.0%












Zhao G35 2010 73 Stage IIIA-IIIB-IV
(Japanese Investigation 
Committee)
Transtrochanteric curved Varus 
osteotomy
12.4 yr 91.8%











Miyanishi K37 2000 125 N/A Transtrochanteric rotational 
osteotomy
13.8 yr 78.0%





Lee Y-K75 2017 65 Stage IIB-III
(Ficat)
Transtrochanteric curved varus 
osteotomy
Minimum 5 yr 89.2%
Maistrelli G40 1988 102 At least Stage II





Atsumi T76 1999 46 Stage II-III-IV (Ficat) Posterior rotational osteotomy 5 yr 70.0%
Ishikwa T39 2015 60 IIIA-IIIB-IV
(Japanese Investigation 
Committee)
High-degree posterior rotational 
osteotomy
1 yr MRI revealed 19.4–
59.5% decrease in 
necrotic lesion in 1 year
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reported an 83% survivorship in Ficat Stage I and 78% sur-
vivorship for Stage II hips at minimum two years follow-
up.36,44 Wang et al found similar success with the lightbulb 
technique, reporting the patients at pre-collapse stage (IIA 
and B) and those presenting with smaller lesions (< 30% of 
the femoral head, or collapse depth < 2 mm) had signifi-
cantly better prognosis (85% survival) than those at post-
collapse stage (IIIC) or with large lesions (60% survival).50
The outcome of non-vascularized bone grafting tech-
niques has not been evaluated by conclusive high-level 
studies. There is controversy over what variables affect the 
outcome and the most optimal technique to use. There is, 
however, agreement in that more successful outcomes 
can be expected when this joint-preservation procedure is 
performed in patients with small to medium sized oste-
onecrotic lesions (see Table 4).13,19,36,44,45
Vascularized bone grafting
A vascularized bone graft with its intact blood supply pro-
vides osteogenic healing potential to the necrotic lesion.36 
Like non-vascularized grafts, vascularized grafts can also 
be beneficial by providing structural support to the bone 
after the necrotic lesion is debrided.13,36 Graft tissue is most 
often taken either from the iliac crest or the fibula.13,15,36,51. 
Urbaniak et al reported on 103 cases of osteonecrosis of 
the femoral head treated with a vascularized fibula graft. 
Patients with Stage II disease had a 91% survivorship rate 
at five years and patients with Stage III disease had a 77% 
survivorship rate in the same follow-up period.51 Studies 
by Eward et al and Yoo et al found survivorship rates of 
89% (average 13.9 years follow-up) and 75% (average 
14.4 years follow-up), respectively.52,53 An additional 
study by Plakseychuk et al retrospectively compared vas-
cularized fibula grafting to non-vascularized fibula graft-
ing and found improved clinical outcomes in the 
vascularized fibula graft cohort (see Table 5).45
Vascularized grafting is not a commonly used tech-
nique, likely due to its surgical complexity.15,19,36,45 Opera-
tive time for a vascularized procedure is on average 210 
minutes with two operative teams being involved, 
 
Fig. 2 (a) Trapdoor technique, allows for direct visualization of the necrotic lesion, curettage and grafting. (b) Re-suturing the 
cartilage flap back to its origin.
 
Fig. 3 (a) Light bulb technique is performed by hinging a cortical window on the femoral neck at the chondral junction and 
curettage of the necrotic lesion to the subchondral bone. (b) An external light source applied form the femoral neck illuminates the 
femoral head trough the surgical tunnel before bone graft impaction.
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 compared to an average of 104 minutes for a trapdoor 
non-vascularized bone graft technique.15
HemiCAP resurfacing
As a last resort for preservation of the hip in advanced 
stages of osteonecrosis, a HemiCAP resurfacing technique 
has been attempted. HemiCAP resurfacing is a bone-con-
serving metallic arthroplasty procedure that preserves all 
of the acetabulum, the viable portion of the femoral head, 
and the femoral neck (see Fig. 4).19 However, the metal 
surface of implant is rarely well tolerated and progressive 
acetabular and femoral head changes make this tech-
nique unfavourable.19 A number of case series and 
matched-cohort studies have shown excellent outcomes 
in the short to mid-term follow-up periods.36 Despite 
these reported short-term findings, there is increased 
concern over complications such as thermal damage, 
periprosthetic fracture, acetabular articular cartilage 
damage and high rates of pain.36 The future of the Hemi-
CAP procedure is uncertain at this point because of the 
Table 4. Outcomes of Lightbulb and Trapdoor technique
Author Study year N (hips) Stage Technique Mean follow-up Outcome/Survival
Gagala J77 2013 21 Stage IIA-IIB-IIC-III-V
(ARCO)
Trapdoor 4 yr 62.0%
Ko J-Y78 1995 10 All collapsed Trapdoor 4.5 yr 100.0%
Seyler TM44 2008 39 Stage II
Stage III
(Ficat&Arlet)
Trapdoor 3 yr 82.0%
47.0%
Mont MA15 1998 30 Stage III-IV Trapdoor 4.8 yr 86.0%
Zhang H-J79 2013 85 Stage IC-IIA-IIB-IIC-IIIA-IIIB-IIIC
(ARCO)
Lightbulb Min 2 years 85.4%
Wang BL50 2010 138 Stage IIA-IIB-IIC-IIIA
(ARCO)
Lightbulb 2.1 yr 68.0%
Yuhan Chang80 2009 11 Stage II-III
(ARCO)
Lightbulb 5 yr 73.0%
Mont MA81 2003 21 Stage II-III
(Ficat)
Lightbulb 4 yr 86.0%
Table 5. Outcomes of vascularised grafting for osteonecrosis
Author Study year N (hips) Stage Technique Mean follow-up Outcome/Survival
Yoo MC53 2008 124 Stage II
Stage III
(Ficat)
FVFG 13.9 yr 88.0%
91.0%
Eward WC52 2012 65 Stage I-II
(Ficat&Arlet)
FVFG 14.4 yr 60.0%




(Marcus, Enneking and 
Massam System)




















FVFG 5 yr 96.0%




















Note. FVFG, free vascularized fibular grafting.
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unfavourable complications that can occur with this use 
of the device.19,36
Conclusion
Avascular necrosis of the femoral head is a serious disease 
encountered in younger patients that can lead to destruc-
tion of the hip joint and the need for THA. The risk of fem-
oral head collapse even in asymptomatic patients creates 
potential for extreme morbidity. Early diagnosis and a 
high index of suspicion is crucial to obtain a favourable 
outcome. MRI is a sensitive and specific screening tool for 
establishing an early diagnosis. In general, the size and 
location of the lesion predicts collapse and disease 
progression.
The orthopaedic community has sought alternatives to 
THA in these young, and often active, patients. The joint-
preservation procedures were introduced with the aim of 
avoiding or postponing the need for THA. With the favour-
able outcomes reported, considerations should be given 
to hip-preservation procedures for patients who meet the 
criteria for such interventions. The most optimal joint- 
preserving procedure remains unknown. Core decom-
pression has been employed for decades and remains a 
viable option in pre-collapse osteonecrosis with small, 
medially located lesions. The addition of biologic regen-
erative agents to core decompression are particularly 
promising as they can introduce new cells to the area of 
necrosis to aid in healing and cellular repair via cytokine 
and growth-factor secretion.
Recent advances in managing ONFH may hold promise 
for patients by preventing or delaying the progression of 
this disease and reducing its associated clinical morbidity. 
In order to create evidence and be able to compare the 
results of various treatment modalities there is a need for 
a standardized classification system that offers accuracy in 
anticipating disease progression and selection of relevant 
treatment option. Additionally, more high-level studies 
are needed to further elucidate and validate a standard-
ized treatment algorithm in order to better care for this 
patient population.
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Fig. 4 (a) A 27-year-old man presenting with right-hip Stage III osteonecrosis with subchondral fracture. Treatment with a metal 
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